Cannabis Elevated Crash Risk in Fatal Accidents While Prescription Drugs Alone Did Not
Analysis of 2,638 driver fatalities found that cannabis (THC >2 ng/mL) and amphetamines elevated crash responsibility risk, while prescription opioids, benzodiazepines, and antidepressants alone did not significantly increase crash risk.
Quick Facts
What This Study Found
Researchers reviewed coroner files and toxicology records of 2,638 fatally injured drivers in Victoria, Australia over 14 years (2000-2013), representing over 97% of all driver fatalities in the study period.
Drugs were found in 34.4% of fatalities. Each driver was assessed for crash responsibility using a validated method. Cannabis (THC >2 ng/mL in blood) and amphetamines were associated with significantly elevated crash risk compared to drug-free drivers.
In contrast, prescription medications alone (opioids, benzodiazepines, antidepressants including SSRIs) did not show significantly elevated crash risk, though benzodiazepines showed a trend. Sedating antihistamines were detected in 1.1% of fatalities.
Key Numbers
2,638 driver fatalities (>97% of all). Drugs found in 34.4%. Alcohol (>=0.05) in 24.8%. Medicinal drugs in 21.2%. Antidepressants: 7.9%. Benzodiazepines: 7.0%. Opioids: 6.6%. Cannabis (THC >2 ng/mL) and amphetamines showed elevated crash risk.
How They Did This
Retrospective analysis of coroner files and toxicology records for all driver fatalities in Victoria, Australia (2000-2013). Crash responsibility was assessed using a validated published method. Drug detection used sensitive analytical limits comparable to those for illicit drugs.
Why This Research Matters
This large dataset provides important context for the drugged driving debate. While cannabis and amphetamines elevated crash risk, commonly prescribed medications that many people worry about (opioids, benzodiazepines, antidepressants) did not show statistically significant increases in crash responsibility when used alone.
The Bigger Picture
This study contributes important real-world data distinguishing between substances that actually elevate crash risk and those that are merely detected in fatally injured drivers. The finding that cannabis elevates crash risk while common prescriptions do not informs both clinical prescribing and traffic safety policy.
What This Study Doesn't Tell Us
This analysis cannot determine impairment at the time of the crash, only the presence of drugs in blood. Tolerance effects (regular prescription users may be less impaired than the blood levels suggest) may explain the null finding for prescription drugs. The THC cutoff of 2 ng/mL may not perfectly separate impaired from non-impaired drivers.
Questions This Raises
- ?Would a higher THC cutoff change the crash risk findings?
- ?Do combinations of prescription drugs and cannabis or alcohol show different risk patterns?
Trust & Context
- Key Stat:
- Cannabis elevated crash risk while prescription medications alone did not
- Evidence Grade:
- This is a large retrospective study covering 97% of driver fatalities over 14 years using a validated crash responsibility method, providing strong epidemiological evidence.
- Study Age:
- Published in 2016, covering 2000-2013 data. Cannabis potency and prescription drug patterns have continued to evolve.
- Original Title:
- The involvement of prescribed drugs in road trauma.
- Published In:
- Forensic science international, 265, 17-21 (2016)
- Authors:
- Drummer, Olaf H(4), Yap, Suwan
- Database ID:
- RTHC-01143
Evidence Hierarchy
Looks back at existing records to find patterns.
What do these levels mean? →Frequently Asked Questions
Is driving on cannabis as dangerous as driving drunk?
This study found that both cannabis and alcohol elevated crash risk, but did not directly compare the magnitude. Other research generally finds alcohol produces greater impairment than cannabis, but both significantly increase the risk of fatal crashes.
Are prescription medications safe to drive on?
In this study, prescription opioids, benzodiazepines, and antidepressants used alone did not significantly elevate crash risk among fatally injured drivers. However, this may reflect tolerance effects in regular users. New prescriptions or dose changes may temporarily impair driving even if long-term use does not show up in crash statistics.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-01143APA
Drummer, Olaf H; Yap, Suwan. (2016). The involvement of prescribed drugs in road trauma.. Forensic science international, 265, 17-21. https://doi.org/10.1016/j.forsciint.2015.12.050
MLA
Drummer, Olaf H, et al. "The involvement of prescribed drugs in road trauma.." Forensic science international, 2016. https://doi.org/10.1016/j.forsciint.2015.12.050
RethinkTHC
RethinkTHC Research Database. "The involvement of prescribed drugs in road trauma." RTHC-01143. Retrieved from https://rethinkthc.com/research/drummer-2016-the-involvement-of-prescribed
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.